-

Tenet Fintech Group Inc. Shareholder Alert: Robbins LLP Informs Investors that Tenet Fintech Group Inc. f/k/a Peak Fintech Group Inc. (PKKFF) is Being Sued for Misleading Investors

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased Tenet Fintech Group Inc. f/k/a Peak Fintech Group Inc. (OTC: PKKFF) securities between September 2, 2021 and October 13, 2021. The complaint alleges violations of the Securities Exchange Act of 1934. Tenet Fintech purports to be the parent company of innovative financial technology subsidiaries operating in China's commercial lending industry.

If you suffered a loss due to Tenet Fintech Group Inc.'s misconduct, click here.

Tenet Fintech Group Inc. (PKKFF) Misled Investors Regarding its Acquisitions

According to the complaint, Tenet Fintech, then known as Peak Fintech Group Inc., began trading on the NASDAQ on September 9, 2021. At that time, the Company, through its wholly owned subsidiary Wuxi Aorong Ltd., purportedly owned 51% of Asia Synergy Financial Capital Ltd. ("ASFC"). On September 14, 2021, the Company issued a press release announcing the acquisition of the Heartbeat Insurance Platform from Huayan Kun Tai Technology Company Ltd. However, the Company did not own 51% of ASFC and Huayan did not own the Heartbeat platform.

On September 28, 2021, Tenet Fintech withdrew its Form 40-K filed with the SEC and stated that its common shares would no longer be listed on the NASDAQ. On September 30, 2021, the Company's shares began trading on the OTC. As a result, the Company's share price fell over 17%, to close at $7.50 on September 30, 2021.

On October 4, 2021 and again on October 13, 2021, Grizzly Reports published articles challenging the ownership of the Company’s assets and noting suspicious transactions and self-dealing.

If you purchased Tenet Fintech Group Inc. (PKKFF) securities between September 2, 2021 and October 13, 2021, you have until January 18, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Tenet Fintech Group Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom